Page last updated: 2024-10-24

chlorambucil and Giant Cell Tumors

chlorambucil has been researched along with Giant Cell Tumors in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Giant Cell Tumors: Tumors of bone tissue or synovial or other soft tissue characterized by the presence of giant cells. The most common are giant cell tumor of tendon sheath and GIANT CELL TUMOR OF BONE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schnitzler, M1
Neher, G1
Marquart, KH1

Other Studies

1 other study available for chlorambucil and Giant Cell Tumors

ArticleYear
[Contribution on the severity of giant cell tumors].
    Fortschritte der Medizin, 1978, Aug-17, Volume: 96, Issue:31

    Topics: Chlorambucil; Doxorubicin; Female; Giant Cell Tumors; Humans; Lung Neoplasms; Middle Aged; Neoplasm

1978